302 related articles for article (PubMed ID: 26794710)
1. Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.
Najar M; Raicevic G; Fayyad-Kazan H; Bron D; Toungouz M; Lagneaux L
Cytotherapy; 2016 Feb; 18(2):160-71. PubMed ID: 26794710
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential.
Song N; Scholtemeijer M; Shah K
Trends Pharmacol Sci; 2020 Sep; 41(9):653-664. PubMed ID: 32709406
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?
Burr SP; Dazzi F; Garden OA
Immunol Cell Biol; 2013 Jan; 91(1):12-8. PubMed ID: 23146942
[TBL] [Abstract][Full Text] [Related]
4. Interactions of mesenchymal stromal/stem cells and immune cells following MSC-based therapeutic approaches in rheumatoid arthritis.
Dehnavi S; Sadeghi M; Tavakol Afshari J; Mohammadi M
Cell Immunol; 2023; 393-394():104771. PubMed ID: 37783061
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells.
Yang G; Fan X; Liu Y; Jie P; Mazhar M; Liu Y; Dechsupa N; Wang L
Stem Cell Rev Rep; 2023 Jul; 19(5):1214-1231. PubMed ID: 37058201
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes.
Ma OK; Chan KH
World J Stem Cells; 2016 Sep; 8(9):268-78. PubMed ID: 27679683
[TBL] [Abstract][Full Text] [Related]
7. Update on Mesenchymal Stem Cells: A Crucial Player in Cancer Immunotherapy.
Taeb S; Rostamzadeh D; Mafi S; Mofatteh M; Zarrabi A; Hushmandi K; Safari A; Khodamoradi E; Najafi M
Curr Mol Med; 2024; 24(1):98-113. PubMed ID: 36573062
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications.
Cagliani J; Grande D; Molmenti EP; Miller EJ; Rilo HLR
J Stem Cell Regen Biol; 2017; 3(2):. PubMed ID: 29104965
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules.
Hazrati A; Malekpour K; Khorramdelazad H; Rajaei S; Hashemi SM
Biomark Res; 2024 Mar; 12(1):35. PubMed ID: 38515166
[TBL] [Abstract][Full Text] [Related]
10. Cell-based therapies for the treatment of rheumatoid arthritis.
Moghaddam MZ; Mousavi MJ; Ghotloo S
Immun Inflamm Dis; 2023 Nov; 11(11):e1091. PubMed ID: 38018576
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation under the lens of real-time in vivo imaging.
Bousso P; Grandjean CL
Eur J Immunol; 2023 Nov; 53(11):e2249921. PubMed ID: 37051691
[TBL] [Abstract][Full Text] [Related]
12. Engineered Cell Membrane-Derived Nanoparticles in Immune Modulation.
Yang Y; Wang K; Pan Y; Rao L; Luo G
Adv Sci (Weinh); 2021 Dec; 8(24):e2102330. PubMed ID: 34693653
[TBL] [Abstract][Full Text] [Related]
13. Electrical Stimulation for Immunomodulation.
Roy Barman S; Jhunjhunwala S
ACS Omega; 2024 Jan; 9(1):52-66. PubMed ID: 38222551
[TBL] [Abstract][Full Text] [Related]
14. Immune Modulatory Cell Therapy in Kidney Transplantation: Hints of a Durable Mechanism of Action.
Griffin MD; Perico N; Casiraghi F
J Am Soc Nephrol; 2023 Jan; 34(1):4-7. PubMed ID: 36719144
[No Abstract] [Full Text] [Related]
15. The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network.
Najar M; Raicevic G; Crompot E; Fayyad-Kazan H; Bron D; Toungouz M; Lagneaux L
J Immunother; 2016; 39(2):45-59. PubMed ID: 26849074
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.
Mo M; Wang S; Zhou Y; Li H; Wu Y
Cell Mol Life Sci; 2016 Sep; 73(17):3311-21. PubMed ID: 27141940
[TBL] [Abstract][Full Text] [Related]
17. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials.
Wang LT; Ting CH; Yen ML; Liu KJ; Sytwu HK; Wu KK; Yen BL
J Biomed Sci; 2016 Nov; 23(1):76. PubMed ID: 27809910
[TBL] [Abstract][Full Text] [Related]
18. Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?
De Becker A; Riet IV
World J Stem Cells; 2016 Mar; 8(3):73-87. PubMed ID: 27022438
[TBL] [Abstract][Full Text] [Related]
19. Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.
Maria AT; Maumus M; Le Quellec A; Jorgensen C; Noël D; Guilpain P
Clin Rev Allergy Immunol; 2017 Apr; 52(2):234-259. PubMed ID: 27207172
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Immunomodulation Properties of Porcine Mesenchymal Stromal/Stem Cells Derived from the Bone Marrow, Adipose Tissue, and Dermal Skin Tissue.
Ock SA; Baregundi Subbarao R; Lee YM; Lee JH; Jeon RH; Lee SL; Park JK; Hwang SC; Rho GJ
Stem Cells Int; 2016; 2016():9581350. PubMed ID: 26798368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
